Consolidated Water expects Hawaii build in H1 2027
The planned facility is sized for 1.7 million gallons of potable water daily, with a 20-year operating term and two additional five-year extensions at the client’s discretion.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Consolidated Water Co. Ltd. updated permitting and anticipated construction timing for the Kalaeloa seawater reverse osmosis desalination project on Oahu, Hawaii. It received State Historic Preservation Division approval of the Preservation Plan and Archaeological Monitoring Plan, and Hawaii Department of Health approval for a Substantial Modification to an Existing Regulated Public Water System. These approvals were required before applications for other permits and approvals could advance.
Several permits and approvals remain outstanding, including a Memorandum of Agreement from the State Historic Preservation Division. Based on the current permitting timeline, construction is now expected to begin in the first half of 2027, compared with the previous expectation of late 2026. In July 2026, the Honolulu Board of Water Supply issued a limited notice to proceed authorizing approximately $6 million for long-lead equipment. The plant is designed to produce 1.7 million gallons of potable water per day; after commissioning, Consolidated Water is contracted to operate and maintain it for 20 years, with two additional five-year extension options at the client’s discretion.
8-K Event Classification
Key Figures
Key Terms
seawater reverse osmosis technical
limited notice to proceed technical
long-lead equipment technical
Substantial Modification to an Existing Regulated Public Water System regulatory
Memorandum of Agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is CWCO's Kalaeloa construction expected to begin?
How much water is the CWCO Kalaeloa plant designed to produce?
Did CWCO receive schedule extensions for the Kalaeloa project?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Date of earliest event reported)
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction of | (Commission File No.) | (IRS Employer Identification No.) |
Incorporation) |
(Address of Principal Executive Offices)
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On October 21, 2026, Consolidated Water Co. Ltd. (the “Company”) issued a press release providing an update on permitting and the anticipated construction schedule for the Kalaeloa seawater reverse osmosis desalination project on Oahu, Hawaii. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. | | Title |
99.1 | Press release issued by the Company on October 21, 2026. | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CONSOLIDATED WATER CO. LTD. | ||
By: | /s/ David W. Sasnett | |
Name: | David W. Sasnett | |
Title: | Executive Vice President & Chief Financial Officer | |
Date: October 21, 2026 | ||
3
Exhibit 99.1
Consolidated Water Advances Permitting for Kalaeloa Seawater Desalination Project in Hawaii
GEORGE TOWN, Grand Cayman, Cayman Islands, October 21, 2026 -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder, and operator of advanced water treatment plants, today provided an update on permitting and the anticipated construction schedule for its Kalaeloa seawater reverse osmosis desalination project on Oahu, Hawaii.
Since the company’s previous update, the project received approval of its Preservation Plan and Archaeological Monitoring Plan from the State Historic Preservation Division and approval from the Hawaii Department of Health for a Substantial Modification to an Existing Regulated Public Water System. These approvals were required before the company could advance its applications for other permits and approvals.
Several permits and approvals remain outstanding, including a Memorandum of Agreement from the State Historic Preservation Division. Based on the current permitting timeline, Consolidated Water now expects construction to begin in the first half of 2027, compared with its previous expectation of late 2026. The Honolulu Board of Water Supply has granted schedule extensions to reflect the permitting process delays.
In July 2026, the Honolulu Board of Water Supply issued a limited notice to proceed authorizing approximately $6 million for the procurement of long-lead equipment. The early procurement is intended to reduce potential scheduling pressure once the remaining permits and approvals are obtained.
The Kalaeloa facility is being developed under Consolidated Water’s contract to design, build, operate, and maintain a seawater reverse osmosis desalination plant capable of producing 1.7 million gallons of potable water per day. Following commissioning, the company is contracted to operate and maintain the facility for 20 years, with two additional five-year extension options at the client’s discretion.
“We continue to make meaningful progress on the Kalaeloa desalination project,” said Consolidated Water CEO Rick McTaggart. “The recent approvals from the State Historic Preservation Division and the Hawaii Department of Health represent important steps in the permitting process and allow us to advance applications for the remaining permits and approvals. While the permitting timeline has shifted our anticipated construction start to the first half of 2027, the Honolulu Board of Water Supply continues to be supportive and has granted schedule extensions to reflect the process. The limited notice to proceed issued in July is also enabling us to procure long-lead equipment now, which should help the project advance efficiently once the remaining permits and approvals are in place.”
About Consolidated Water Co. Ltd.
Consolidated Water Co. Ltd. develops and operates advanced water treatment plants and water distribution systems. The company designs, constructs, and operates seawater desalination facilities in the Cayman Islands, The Bahamas, and the British Virgin Islands, and designs, constructs, and operates water treatment and reuse facilities in the United States.
The company also manufactures and services a wide range of products and provides design, engineering, management, operating, and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment.
For more information, visit cwco.com.
Cautionary Note Regarding Forward-Looking Statements
This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “project,” “intend,” “expect,” “should,” “will” or similar expressions. This press release contains, or may be deemed to contain, “forward-looking statements” (as defined in the U.S. Private Securities Litigation Reform Act of 1995), including statements regarding the anticipated construction schedule and completion of the Kalaeloa desalination facility; the effect of permitting delays on that schedule; the timing and receipt of the remaining permits and approvals; the company’s and the Honolulu Board of Water Supply’s efforts to mitigate those delays; and the company’s ability to perform its design, build, operate, and maintain obligations with respect to the Kalaeloa facility, including the anticipated 20-year operating term and any exercise of the related extension options. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, (i) continued acceptance of the company's products and services in the marketplace; (ii) changes in its relationships with the governments and clients of the jurisdictions in which it operates, including the Honolulu Board of Water Supply; (iii) the timing and outcome of permitting and other regulatory approvals affecting the Kalaeloa facility; (iv) the company’s ability to procure equipment and perform its contractual obligations on the anticipated timeline and budget, including with respect to the Kalaeloa facility and the Florida purchase orders; (v) changes in demand, consumption levels, operating costs, energy costs, weather, and economic conditions in the jurisdictions in which the company operates; and (vi) various other risks such as economic, operational, and industry-specific risks, as detailed in the company's periodic report filings with the Securities and Exchange Commission (“SEC”). For more information about risks and uncertainties associated with the company’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of the company’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q, copies of which may be obtained by contacting the company’s Secretary at the company’s executive offices or at the “Investors – SEC Filings” page of the company’s website at ir.cwco.com/docs. Except as otherwise required by law, the company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
2
Company Contact:
David W. Sasnett
Executive Vice President and CFO
Tel (954) 509-8200
Email Contact
Investor & Media Contact:
Ron Both or Grant Stude
Encore Investor Relations
Tel (949) 432-7450
Email Contact
3